
Nate Silver @NateSilver538
Anyway, I don't think AstraZeneca is in the same bucket as J&J. The clinical trial data is a lot more complicated and so is the question of what role it serves when we have 3 other vaccines to deploy (again, presuming J&J approval). I'd want the FDA to think carefully on it. — PolitiTweet.org